Wildcat Capital Management, LLC
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 2, 2025), Wildcat Capital Management, LLC reported 8 stock positions worth $187.4 million. Its top holding was Frontier (ULCC) at 65.0% of the portfolio, followed by RLX Technology Inc.-ADR (RLX, 18.1%) and Tic Solutions (TIC, 8.9%). Compared with Q4 2024, it opened 2 new positions and sold out of 2. The biggest buy was a new position in Tic Solutions (TIC) and the biggest sale an exit from Gitlab Class A (GTLB).
- Most Recent 13F
- Q2 2026
- Location
- NEW YORK, NY
- CIK
- 0001582384
- Portfolio Value
- $187.4M (Q1 2025)
- SEC Filing
- 0001999371-25-005352 ↗ filed May 2, 2025
Holdings Value
Holdings 8 stocks · $187.4M
| ULCC Frontier Group Holdings Inc. | 64.99% | 28,061,351 | $121.8M | No change |
| RLX RLX Technology Inc.-ADR | 18.11% | 18,046,195 | $33.9M | No change |
| TIC Tic Solutions Inc. filed as ACUREN CORP | 8.90% | 1,500,000 | $16.7M | New |
| URGN Urogen Pharma Ltd. | 2.93% | 495,606 | $5.5M | No change |
| ALLO Allogene Therapeutics Inc. | 2.28% | 2,920,787 | $4.3M | No change |
| CNTA Centessa Pharmaceuticals Ltd. | 2.16% | 281,859 | $4.1M | New |
| KRON Kronos Bio Inc. | 0.57% | 1,297,959 | $1.1M | No change |
| SLXN Silexion Therapeutics Corp. | 0.07% | 113,428 | $125K | No change |
Portfolio Sells Q4 2024 → Q1 2025
Portfolio Buys Q4 2024 → Q1 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 3 | $228.5M | ULCC, ALLO, CHYM |
| Q1 2026 | 2 | $106.2M | ULCC, ALLO |
| Q4 2025 | 3 | $136.5M | ULCC, ALLO, PCOR |
| Q3 2025 | 5 | $145.1M | ULCC, RLX, ALLO, TTAN, GTLB |
| Q2 2025 | 6 | $168.3M | ULCC, RLX, TIC, URGN, ALLO |
| Q1 2025 | 8 | $187.4M | ULCC, RLX, TIC, URGN, ALLO |
| Q4 2024 | 8 | $252.7M | ULCC, RLX, ALLO, URGN, KRON |
| Q3 2024 | 7 | $204.6M | ULCC, RLX, ALLO, URGN, SKILLZ INC |
| Q2 2024 | 16 | $408.6M | ULCC, FYBR, MCO, MSFT, RLX |
| Q1 2024 | 16 | $275.5M | FYBR, GSHD, MCO, MSFT, RLX |